微創醫療(00853.HK)因可換股債獲兑換髮行168.35萬股
格隆匯12月9日丨微創醫療(00853.HK)發佈公告,有關發行1億美元於2020年到期的可換股債券。公司近期接獲債券持有人有關行使附於債券的換股權以按照兑換價每股股份6.84港元兑換未償還本金總額為148.1006萬美元的債券的兑換通知。據此,168.3453萬股新股份(相當於公司於緊接該等兑換前已發行股本約0.10395%及公司經發行新股份擴大的已發行股本約0.10384%)已根據債券條款及條件配發予債券持有人。於該等兑換完成後,債券未償還本金總額將減至8441.0468萬美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.